NCT07053579Completed
Cross-cultural Adaptation and Validation of the P-CIN for Chinese Pediatric Oncology Patients
Cross-cultural Adaptation and Validation of the Pediatric Chemotherapy-induced Neuropathy (P-CIN) for Chinese Pediatric Oncology Patients: A Multi-center Study
Source: ClinicalTrials.gov · Last updated 8 Jul 2025
Brief summary (registry, in English)
The goal of this study was to conduct a cross-cultural adaptation of the P-CIN into the Chinese context, assess its psychometric properties, and determine the cut-off value of CIPN among Chinese pediatric oncology patients. Participants provided demographic and clinical characteristics, and complete the translated P-CIN, Wong-baker FACES Pain Rating scale for pain, and Chinese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module for quality of life.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 313 (actual)
- First submitted
- 18 Jun 2025
- Start date
- 5 Jan 2025
- Primary completion date
- 30 May 2025
- Lead sponsor
- The Hong Kong Polytechnic University
- Diseases
- Childhood cancers
- NCT number
- NCT07053579
What you commit to
- Study type: Observational
- Participants enrolled: 313
- From 5 Jan 2025 to the primary completion date, 30 May 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (1) had a diagnosis of cancer in the central nervous system (CNS) cancer, cancer relapse or secondary cancer
- (3) planned to receive multiple cancer treatment (e.g., radiotherapy and immunotherapy)
- (4) suffered from other neuromuscular diseases (e.g., traumatic brain injury and cerebral palsy)
- (5) had a developmental deficit (e.g., Down's syndrome and other chromosomal disorders)
- (6) have suffered from psychiatric diseases or used antipsychotic drugs
- (7) had peripheral neuropathy symptoms caused by diabetes, genetic diseases, spinal cord injury, or alcoholism, or
- (8) had other neuromuscular disorders (e.g., traumatic brain injury, cerebral palsy).
Other
- (2) in the terminal stage
Who the study is looking for
- (1) 6 to 18 years of age
- (2) were diagnosed with cancer
- (3) had received or were currently receiving neurotoxic chemotherapy drugs (e.g., Vincristine, Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel, Docetaxel, Ixabepilone, Bortezomib, Thalidomide)
- (4) were able to communicate, read, and write in Chinese without significant hearing and vision problems to ensure they understood the P-CIN.
Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ka Yan Ho Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
| The Hong Kong Polytechnic University Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.